Can AstraZeneca Sustain Sector-Beating Growth? Its Buying Spree Could Help

AstraZeneca has maintained sector-beating growth for five years, but is looking to a new wave of bolt-on acquisitions and licensing deals to sustain that trajectory beyond 2030.